Affordable Access

deepdyve-link
Publisher Website

Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study.

Authors
  • Fenelon, M1
  • Quinque, E2
  • Arrive, E3
  • Catros, S4
  • Fricain, J C4
  • 1 Department of Dentistry, University of Bordeaux, Bordeaux, France; University of Bordeaux, 16 à 20, cours de la Marne 33082 Bordeaux France. Electronic address: [email protected] , (France)
  • 2 Department of Dentistry, University of Bordeaux, Bordeaux, France. , (France)
  • 3 Department of Dentistry, University of Bordeaux, Bordeaux, France; University of Bordeaux, 16 à 20, cours de la Marne 33082 Bordeaux France; University of Bordeaux, ISPED, Centre INSERM U897-Epidémiologie-Biostatistique, Bordeaux, France. , (France)
  • 4 Department of Dentistry, University of Bordeaux, Bordeaux, France; University of Bordeaux, 16 à 20, cours de la Marne 33082 Bordeaux France. , (France)
Type
Published Article
Journal
International journal of oral and maxillofacial surgery
Publication Date
Nov 01, 2017
Volume
46
Issue
11
Pages
1505–1511
Identifiers
DOI: 10.1016/j.ijom.2017.03.032
PMID: 28473243
Source
Medline
Keywords
License
Unknown

Abstract

This retrospective study aimed to evaluate the efficacy of clonazepam and amitriptyline in the treatment of burning mouth syndrome (BMS). A single-centre retrospective cohort study was performed among patients diagnosed with BMS. Either clonazepam or amitriptyline was administered. Patients were asked to evaluate their pain using a 10-point verbal numerical scale (VNS) at baseline, and at 6 weeks and 3 months of treatment. Mean pain-relief values were assessed according to the treatment received using the Kruskal-Wallis test. Thirty-nine patients (85% female) were included. The mean age was 65±10.5years. The mean VNS score at baseline was 7.1±2.0 in patients treated with clonazepam and 7.5±1.1 in those treated with amitriptyline. The mean VNS scores in the clonazepam and amitriptyline groups were 4.9±2.4 and 6.1±2.6, respectively, after 6 weeks of treatment (P=0.498) and 4.4±2.0 and 4.1±2.7, respectively, after 3 months (P=0.509). There was no difference between the two treatments in terms of pain reduction. Clonazepam as well as amitriptyline may be an effective treatment for BMS.

Report this publication

Statistics

Seen <100 times